BI
Biofil Chemicals & Pharmaceuticals Ltd (BIOFILCHEM)
₹29.95
Mkt cap
₹53 Cr
P/E ratio
111.00
P/B
2.27
Div yield
0.00%
ROE
−2.83%
ROCE
2.97%
EPS (TTM)
₹0.27
Book value
₹13
52W range
26–46
Sector
Healthcare
Price history
Previous close
Incorporated in 1993, Biofil Chemicals and Pharmaceuticals Ltd deals in Pharmaceuticals and Chemicals products. [1]
NSE BIOFILCHEMBSE 524396
Health check
Cautious
ValuationExpensive
ProfitabilityWeak
GrowthHigh
TechnicalsBearish
52-week range
−35.37% from high₹30
₹26+16.99% from low₹46
Current
₹29.95
Prev close
₹30.05
Day
−0.33%
Price performance
1D
−0.33%
1W
−4.95%
1M
−6.32%
3M
−10.81%
6M
+9.19%
1Y
−27.92%
YTD
−10.57%
Financials
Revenue, profit & margin
P/E ratio
111.0×
BIOFILCHEM is 221% above the sector median of 34.6×
BIOFILCHEM111.0×
Sector median34.6×
| Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | Trend | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 2.43 | 17.37 | 5.03 | 15.20 | 8.44 | 2.41 | 14.20 | 8.35 | 6.43 | 13.54 | 0.86 | 7.57 | 12.35 | |
| Expenses | 2.01 | 17.13 | 4.84 | 15.24 | 8.13 | 2.29 | 13.89 | 8.24 | 6.42 | 13.42 | 0.77 | 7.14 | 12.21 | |
| Operating Profit | 0.42 | 0.24 | 0.19 | -0.04 | 0.31 | 0.12 | 0.31 | 0.11 | 0.01 | 0.12 | 0.09 | 0.43 | 0.14 | |
| OPM % | 17.28% | 1.38% | 3.78% | -0.26% | 3.67% | 4.98% | 2.18% | 1.32% | 0.16% | 0.89% | 10.47% | 5.68% | 1.13% | |
| Other Income | 0.02 | 0.03 | 0.03 | 0.41 | 0.03 | 0.02 | 0.02 | 0.24 | 2.83 | 0.06 | 0.08 | 0.11 | 0.06 | |
| Interest | 0.01 | 0.01 | 0.00 | 0.02 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Depreciation | 0.11 | 0.11 | 0.11 | 0.08 | 0.10 | 0.10 | 0.10 | 0.08 | 0.07 | 0.07 | 0.07 | 0.07 | 0.07 | |
| Profit before tax | 0.32 | 0.15 | 0.11 | 0.27 | 0.23 | 0.03 | 0.22 | 0.26 | 2.76 | 0.11 | 0.10 | 0.47 | 0.13 | |
| Tax % | 25.00% | 20.00% | 18.18% | 11.11% | 26.09% | 33.33% | 27.27% | 23.08% | 12.68% | 27.27% | 30.00% | 55.32% | 23.08% | |
| Net Profit | 0.24 | 0.12 | 0.09 | 0.25 | 0.17 | 0.02 | 0.16 | 0.20 | 2.41 | 0.08 | 0.08 | 0.21 | 0.11 | |
| EPS in Rs | 0.15 | 0.07 | 0.06 | 0.15 | 0.10 | 0.01 | 0.10 | 0.12 | 1.48 | 0.05 | 0.05 | 0.13 | 0.07 | |
| Raw PDF |
Earnings
Results dates & reactionsNo upcoming results date on calendar.
Fresh quarters land in the Financials table above, tagged NSE until screener catches up.
Avg earnings-day move +0.09% · closed higher next day 0 of last 1
| Q1FY27 | |
|---|---|
| Broadcast | 11 Aug '26◦ |
| Earnings day | +0.09% |
| +1 day | −2.57% |
| +5 days | −5.30% |
| +15 days | −2.11% |
| +30 days | −0.95% |
| Filing | XBRL |
Corporate actions
Last 6 monthsNo recent corporate actions
Dividends, splits, and bonuses in the last six months show up here.
Results analysis
Shareholding
as of Jun 202646.79%Promoter
Promoters46.79%
FIIs0.00%
DIIs0.08%
Public53.13%0.01
Ownership trend
Peers
8 companiesValuation vs quality
P/E × ROCE · bubble = market cap| Name | CMP | P/E | Mkt Cap | Div Yld | NP Qtr | Qtr Profit Var | Sales Qtr | Qtr Sales Var | ROCE |
|---|---|---|---|---|---|---|---|---|---|
| Sun Pharma.Inds. | ₹1,837.30 | 34.90 | 4,40,830 | 0.87% | 2,901 | +5.95% | 15,300 | +10.46% | 20.53% |
| Divi's Lab. | ₹9,375.00 | 83.54 | 2,48,877 | 0.32% | 902 | +65.50% | 3,080 | +27.80% | 21.97% |
| Torrent Pharma. | ₹4,840.00 | 82.51 | 1,84,098 | 0.79% | 566 | +5.79% | 4,921 | +54.85% | 15.19% |
| Zydus Lifesci. | ₹1,160.00 | 23.77 | 1,15,710 | 0.09% | 990 | −35.09% | 8,017 | +21.96% | 21.14% |
| Cipla | ₹1,394.50 | 31.48 | 1,12,656 | 0.93% | 786 | −39.19% | 7,119 | +2.33% | 15.49% |
| Laurus Labs | ₹1,954.00 | 96.56 | 1,05,577 | 0.10% | 362 | +125.49% | 2,026 | +29.10% | 17.76% |
| Aurobindo Pharma | ₹1,734.00 | 26.39 | 99,771 | 0.23% | 1,032 | +28.11% | 9,150 | +16.30% | 12.86% |
| Biofil Chemicals | ₹32.83 | 111.27 | 53 | 0.00% | 0 | −95.44% | 12 | +92.07% | 2.97% |
| Median: 158 Co. | ₹433.90 | 34.56 | 2,205 | 0.08% | 13 | +29.57% | 164 | +18.57% | 14.96% |
Filings
Annual reports15
Announcements5
Announcement under Regulation 30 (LODR)-Newspaper Publication 28 Aug - Pursuant to Regulation 30, 44 and 47 of SEBI(LODR) Regulations, 2015 and in compliance with Section 108 of the Companies Act, 2013 read with rule …Information Regarding E-Voting For 41St Annual General Meeting 26 AugIntimation For Dispatch Of Letter To Those Shareholders Whose E-Mail Addresses Are Not Registered With Company/Registrar & Transfer Agent/Depository Participants 26 Aug - 41st AGM on 23 September 2026; annual report and notice shared with shareholders lacking registered emails.Reg. 34 (1) Annual Report. 26 Aug - Company issued 2025-26 annual report; 41st AGM on 23 Sept 2026, including ₹20 crore related-party approval.Submission Of Notice Of Convening 41St AGM Of The Company. 26 Aug